Accessibility Menu
Shanghai Int Medical Instruments logo

Shanghai Int Medical Instruments(SEHK) 1501

Market CapHK$7.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+39%
5 Year+26%
1 Year+11%
1 Month+5%
HK$35.10
-0.23%
-0.08Today
Shanghai Int Medical Instruments last closing stock price
MetricPriceDate
Last closeHKD 35.102026-08-31
Shanghai Int Medical Instruments stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.63%HKD 34.202026-08-24
1 month+5.28%HKD 33.342026-07-31
3 month+6.04%HKD 33.102026-06-02
Year to date+17.08%HKD 29.982025-12-31
1 year+11.43%HKD 31.502025-08-29
3 year+25.58%HKD 27.952023-08-31
5 year+26.03%HKD 27.852021-09-01
Since inception+39.09%HKD 25.292019-11-08

Shanghai Int Medical Instruments Financials at a Glance

Market Cap

HK$7.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥2.11B

Net Income (TTM)

CN¥418.96M

EPS (TTM)

HK$1.33

P/E Ratio

26.48

Dividend

HK$0.26

Beta (Volatility)

0.06 (Low)

Price

HK$35.10

Volume

155,000

Open

HK$35.18

Previous Close

HK$35.18

Daily Range

HK$34.46 - HK$35.46

52-Week Range

HK$27.86 - HK$41.40

Estimated Earnings Date

Mar 22, 2027

1501 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shanghai Int Medical Instruments

Shanghai Kindly Medical Instruments Co., Ltd. is a leading manufacturer specializing in cardiovascular interventional medical devices. Established in 2006 and headquartered in Shanghai, the company has a strong presence in both domestic and international markets, providing innovative solutions to healthcare providers.

Products and Services
  • Guiding catheters and micro catheters for interventional procedures
  • Inflation devices and single-use medical accessories
  • Comprehensive range of surgical tools and kits for various medical applications
Growth Outlook
  • Revenue of CNY 604.4 million in Q4 2025, a significant increase from previous quarters
  • Net income of CNY 120.3 million in Q4 2025, reflecting strong operational efficiency
  • Continued expansion into international markets, enhancing global reach and sales
Financial Highlights
  • Trailing twelve months (TTM) revenue of CNY 2.1 billion, showcasing consistent growth
  • Operating profit margin of 25.4% TTM, indicating effective cost management
  • Net profit margin of 20.5% TTM, demonstrating strong profitability
Shanghai Kindly Medical Instruments Co., Ltd. has established itself as a key player in the medical instruments industry, particularly in cardiovascular solutions. The company's diverse product offerings cater to a wide range of medical needs, ensuring a robust market presence. Recent financial performance highlights a strong upward trend in revenue and profitability, positioning the company favorably for future growth. With a commitment to innovation and quality, Shanghai Kindly Medical Instruments is well-equipped to capitalize on emerging opportunities in the healthcare sector.
AI Generated • Aug 11, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

2,088

CEO

Dong Ke Liang, PhD

Website

www.kdl-int.com

Headquarters

Shanghai, SH 201803, CN

1501 Financials

Key Financial Metrics (TTM)

Gross Margin

60.85%

Operating Margin

22.99%

Net Income Margin

19.21%

Return on Equity

9.64%

Return on Capital

10.01%

Return on Assets

5.91%

Earnings Yield

3.78%

Dividend Yield

0.74%

Payout Ratio

0.00%

Stock Overview

Market Cap

HK$7.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

209.34M

Volume

155.00K

Avg. Volume

222.33K

Financials (TTM)

Gross Profit

CN¥1.29B

Operating Income

CN¥502.69M

EBITDA

CN¥655.39M

Operating Cash Flow

CN¥571.80M

Capital Expenditure

-CN¥191.04M

Free Cash Flow

CN¥380.76M

Cash & ST Invst.

CN¥1.32B

Total Debt

CN¥716.25M

Shanghai Int Medical Instruments Performance Analysis

Shanghai Int Medical Instruments annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 681,310,56721.7%
20232023-12-31CNY 831,882,27222.1%
20242024-12-31CNY 923,708,84011.0%
20252025-12-31CNY 1,155,534,70725.1%
Shanghai Int Medical Instruments sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3117.2%
Q22025-06-300.3%
Q42025-12-3131.1%
Q22026-06-30-2.7%
Shanghai Int Medical Instruments annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.91-11.9%
20232023-12-31CNY 1.0111.2%
20242024-12-31CNY 1.2220.5%
20252025-12-31CNY 1.3611.7%
Shanghai Int Medical Instruments sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-15.5%
Q22025-06-3016.3%
Q42025-12-3112.3%
Q22026-06-30-15.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥587.83M

+49.8%

Gross Profit

CN¥359.35M

+45.6%

Gross Margin

61.13%

N/A

Market Cap

HK$7.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$3.53M

N/A

Employees

2,088

N/A

Net Income

CN¥108.80M

+8.2%

EBITDA

CN¥184.50M

+34.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥1.32B

+264.2%

Total Debt

CN¥716.25M

+959.9%

Accounts Receivable

CN¥96.51M

+29.8%

Inventory

CN¥204.93M

+33.3%

Long Term Debt

CN¥81.78M

+410.0%

Short Term Debt

CN¥634.47M

+1131.0%

Return on Assets

5.91%

N/A

Return on Invested Capital

9.28%

N/A

Free Cash Flow

CN¥212.14M

+217.8%

Operating Cash Flow

CN¥223.60M

+99.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 1501

What is the current price of Shanghai Int Medical Instruments?

Shanghai Int Medical Instruments is trading at HK$35.10 per share.

What is the 52-week range for Shanghai Int Medical Instruments?

Over the past 52 weeks, Shanghai Int Medical Instruments has traded between HK$27.86 and HK$41.40.

How much debt does Shanghai Int Medical Instruments have?

As of the most recent reporting period, Shanghai Int Medical Instruments reported total debt of CN¥797.44M.

How much cash does Shanghai Int Medical Instruments have on hand?

Shanghai Int Medical Instruments reported CN¥703.34M in cash and cash equivalents in its most recent financial results.

What is Shanghai Int Medical Instruments’s dividend yield?

Shanghai Int Medical Instruments currently has a dividend yield of 0.74%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services